TORONTO, March 15, 2023 (GLOBE NEWSWIRE) -- Field Trip Health & Wellness Ltd. (TSX-V: FTHW) ("Field Trip" or the "Company") today announced that, in an effort to reduce expenditures and preserve capital, it will be closing the Field Trip Health Centres located in Chicago, Washington DC, Seattle, San Diego and Fredericton. The anticipated last day of operation for each of these locations will be on or around April 15, 2023.
Clients in each of these locations will be receiving notice of clinic closures which will include, among other things, information on finding alternative care providers, how to access their medical records and other information required by applicable laws and regulations.
The Independent Committee (the "IC") of the board of directors of the Company that was formed in December 2022 to assess strategic options for the Company, along with the IC's financial and legal advisors, continue to review the Company's operations and investigate alternate courses of actions including, but not limited to, further cost reductions, restructuring, the potential sublease or closure of clinic locations and settlement of lease obligations (the "Strategic Review"). The Company does not intend to comment further on the Strategic Review, unless and until the Board has approved a specific course of action or otherwise determined that further disclosure is appropriate or required by law.
About Field Trip Health & Wellness Ltd.
With a large global community of psychedelic-interested people, proprietary psychedelic therapies that generate transformative results for people in the treatment of mental health conditions and a brand and share of voice that is reaching millions of people, Field Trip is a center of gravity for the psychedelic renaissance.
Learn more at and
Follow us on Twitter and Instagram: @fieldtriphealth
To receive company updates about Field Trip and to be added to the email distribution list please sign up here.
Cautionary Note Regarding Forward-Looking Information
This release includes forward-looking information (within the meaning of Canadian securities laws and within the meaning of the United States Private Securities Litigation Reform Act of 1995) regarding the Company and its business. Often but not always, forward-looking information can be identified by the use of words such as "expect", "intends", "anticipated", "believes" or variations (including negative variations) of such words and phrases, or state that certain actions, events or results "may", "could", "would" or "will" be taken, occur or be achieved. Such statements are based on the current expectations and views of future events of the management of the Company and are based on assumptions and subject to risks and uncertainties. Although the management believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect. The forward-looking events and circumstances discussed in this release may not occur and could differ materially as a result of known and unknown risk factors and uncertainties affecting the companies. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. Accordingly, readers should not place undue reliance on any forward-looking statements or information. No forward-looking statement can be guaranteed. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and the Company does not undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise. Additional information relating to the Company, can be located on the SEDAR website at .
Neither the TSX Venture Exchange, nor its Regulation Services Provider, have approved the contents of this release or accept responsibility for the adequacy or accuracy of this release.
CONTACTS:
Field Trip Health & Wellness:
Ronan Levy
Chairman & CEO
(416) 505-0929
ronan@fieldtriphealth.com
Investor contacts:
Phil Carlson / Sophia Bashford
KCSA Strategic Communications
(646) 573-0776) / (929 246-7307)
fieldtripIR@kcsa.com
Media contacts:
Isabella Morreale
Autumn Communications
(862) 579-7944
press@fieldtriphealth.com
SOURCE Field Trip Health & Wellness Ltd.
多伦多,2023年3月15日(环球通讯社)--实地考察健康与健康有限公司(多伦多证券交易所股票代码:FTHW)(以下简称“实地考察”或“公司”)今天宣布,为了减少开支和节约资本,将关闭位于芝加哥、华盛顿特区、西雅图、圣地亚哥和弗雷德里克顿的实地考察卫生中心。预计这些地点的最后一天将于2023年4月15日或前后投入运营。
这些地点的客户将收到诊所关闭的通知,其中除其他外,将包括寻找替代护理提供者的信息、如何获取他们的医疗记录以及适用法律和法规要求的其他信息。
本公司董事会独立委员会于2022年12月成立,以评估本公司的策略选择,连同独立委员会的财务及法律顾问,继续检讨本公司的营运及研究其他行动方案,包括但不限于进一步削减成本、重组、可能转租或关闭诊所地点及清偿租赁责任(“策略检讨”)。本公司不打算就策略检讨作出进一步评论,除非及直至董事会已批准一项具体行动方案或以其他方式决定进一步披露是适当的或法律规定的。
关于野外旅行健康与健康有限公司。
拥有一个庞大的全球迷幻人群社区,专有的迷幻疗法可以为人们的心理健康治疗带来革命性的结果,而且有一个品牌和分享的声音正在接触到数百万人,菲尔德旅行是迷幻复兴的重心。
了解更多信息,请访问和
在推特和Instagram上关注我们:@fieldtriphealth
要接收有关实地考察旅行的公司更新并将其添加到电子邮件分发列表中,请在此处注册。
关于前瞻性信息的注意事项
本新闻稿包括有关该公司及其业务的前瞻性信息(符合加拿大证券法和1995年美国私人证券诉讼改革法的定义)。前瞻性信息往往但不总是可以通过使用诸如“预期”、“打算”、“预期”、“相信”或这些词语和短语的变体(包括负面变体)来确定,或者声明某些行动、事件或结果“可能”、“可能”、“将”或“将”被采取、发生或实现。这些陈述是基于公司管理层对未来事件的当前预期和看法,是基于假设的,受风险和不确定因素的影响。尽管管理层认为这些陈述所依据的假设是合理的,但它们可能被证明是不正确的。本新闻稿中讨论的前瞻性事件和情况可能不会发生,可能会因影响这些公司的已知和未知风险因素和不确定性而大不相同。尽管公司试图确定可能导致实际行动、事件或结果与前瞻性陈述中描述的大不相同的重要因素,但可能还有其他因素导致行动、事件或结果与预期、估计或预期的不同。因此,读者不应过分依赖任何前瞻性陈述或信息。任何前瞻性陈述都不能得到保证。除适用的证券法要求外,前瞻性表述仅在作出之日发表,公司不承担任何公开更新或修改任何前瞻性表述的义务,无论是由于新信息、未来事件或其他原因。有关公司的更多信息,可在SEDAR网站上找到。
多伦多证券交易所创业板交易所及其监管服务提供商均未批准本新闻稿的内容,也未对本新闻稿的充分性或准确性承担责任。
联系人:
实地考察健康与健康:
罗南·利维
董事长兼首席执行官
(416)505-0929
邮箱:ronan@fieldtriphelth.com
投资者联系方式:
菲尔·卡尔森/索菲亚·巴什福德
KCSA战略传播
(646)573-0776)/(929 246-7307)
邮箱:fieldtripIR@kcsa.com
媒体联系人:
伊莎贝拉·莫里亚尔
秋季通信
(862)579-7944
按下@fieldtriphelth.com
来源:野外旅行健康健康有限公司。